Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2003
10/02/2003WO2003080063A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2003016316A8 Diazacycloalkanes as oxytocin agonists
10/02/2003US20030187277 Cosmetics; applying color to skin, hair, nails
10/02/2003US20030187263 Viricides
10/02/2003US20030187258 Bactericides
10/02/2003US20030187253 Synthesis of pyrrolo[2,1-c][1,4]benzodiazepine analogues
10/02/2003US20030187252 Porphyrin compounds consisting of porphyrin rings fused in a single direction by three bonds, i.e., one meso-meso carbon bond and two beta-beta carbon bonds and process for their synthesis
10/02/2003US20030187251 Porphyrin array having imidazolyl porphyrin metal complex as structural unit thereof and method of producing the same
10/02/2003US20030187250 Novel compound and method for synthesizing the same, ink, ink cartridge, recording unit, ink-jet recording apparatus, recording method, liquid composition, pattern generating method, article, environmental history-detecting method
10/02/2003US20030187188 Synthesis of peptoid substituted azole compounds
10/02/2003US20030187106 Fluorescent diketopyrrolopyrroles
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187001 4-aminopyrrolopyrimidines as kinase inhibitors
10/02/2003US20030186997 2,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonsulsive action and methods for producing the same
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186983 C-5 Modified indazolylpyrrolotriazines
10/02/2003US20030186982 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
10/02/2003US20030186082 Organic light-emitting diode
10/02/2003US20030183577 Method for the synthesis and evaluation of porphyrins, calix (4) pyrroles and allied macrocycles
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2479766A1 Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances
10/02/2003CA2479277A1 Fused bicyclic pyrimidine derivatives
10/02/2003CA2477651A1 Kinase inhibitors
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003CA2451516A1 Agent for preventing or treating diseases caused by enos expression
10/01/2003EP1348708A1 Heteroaryl substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348695A1 Derivatives of paraphenylene diamine with pyrrolidine groups substituted by cationic radicals and their use for dyeing keratinic fibre
10/01/2003EP1347982A2 Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
10/01/2003EP1347981A1 Condensed purine derivatives as a 1? adenosine receptor antagonists
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347979A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
10/01/2003EP1347978A1 Novel substituted imidazotriazinones as pde ii-inhibitors
10/01/2003EP1347977A1 Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP1347679A1 Method of inactivating viral particles in a blood product
10/01/2003EP1105393B1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
10/01/2003EP1097153B1 Novel triazolo[4,5-d]pyrimidine compounds
10/01/2003EP0996621B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
10/01/2003EP0811008B1 Bicyclic benzazepine derivatives as vasopressin antagonists
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
09/2003
09/30/2003US6627756 Vaporization, crystallization, purification
09/30/2003US6627754 Pyrrolo[2,3-d]pyrimidine compounds
09/30/2003US6627753 Agricultural insecticides
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627630 Preventing or treating allergic skin diseases such as contact dermatitis, pruritus, dried dermatitis, acute urticaria prurigo and antiallergins
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003US6627288 Optical recording medium and porphycene compound
09/30/2003US6627176 Therapy; diagnosis
09/25/2003WO2003078436A1 Porphyrin derivatives, method for the production thereof, pharmaceutical compositions and use thereof
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078423A1 Compositions useful as inhibitors of protein kinases
09/25/2003WO2003078420A2 Process for making chiral 1,4-disubstituted piperazines
09/25/2003WO2003078397A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003WO2003078384A1 Multidentate ligand, multi-nucleus metal complex, metal complex chain, metal complex integrated structure, and preparation method thereof
09/25/2003WO2003077949A2 Methods of treating diabetes using pde 11a inhibitors
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003022847A3 Process for the direct preparation of pyrrolo[3,4-c]pyrroles
09/25/2003WO2002011670A3 Solid forms of tin ethyl etiopurpurin and processes for producing such forms
09/25/2003US20030181753 Method for producing amides or esters
09/25/2003US20030181635 Process for coupling amino acids to an antifolate scaffold
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181485 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
09/25/2003US20030181470 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
09/25/2003US20030181469 Crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
09/25/2003US20030181467 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
09/25/2003US20030181459 Use of a vitamin combination for the treatment of primary headaches
09/25/2003US20030181457 Tertiary amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular and sexual disorders
09/25/2003US20030181455 Bicyclic and tricyclic hetroaromatic compounds
09/25/2003US20030181454 Nitrogen compounds and prodrugs used as type-II secretory phospholipase(sPLA2) agonists or antagonists, for prevention cancer, cirrhosis, Alzheimer's disease and/or arteriosclerosis
09/25/2003US20030181452 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
09/25/2003US20030181449 Methods and compositions for the treatment of pain
09/25/2003US20030181446 Novel N-acylated heterocycles
09/25/2003US20030181439 Use of paullone derivatives for making medicines
09/25/2003US20030181438 Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
09/25/2003US20030180392 Process for the production of vasicine
09/25/2003US20030180224 Photosensitisers
09/25/2003CA2479069A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003CA2477906A1 Process for making chiral 1,4-disubstituted piperazines
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/24/2003EP1346993A1 Lactam compounds and medicinal use thereof
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345942A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
09/24/2003EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
09/24/2003EP1345939A2 Method for producing sulfonamide-substituted imidazotriazinones
09/24/2003EP1345938A1 Tricyclic crf receptor antagonists
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 573